HE use of newer imaging modalities is constantly shaping the field of neurooncology. Older, static imaging systems are being augmented by newer systems with real-time and functional capabilities. This innovation in imaging technology is allowing surgeons to plan and execute more precise tumor resections and to achieve GTR in tumors for which such resections would have previously been more difficult.
surgical field after some of the tumor or cerebrospinal fluid has been removed, allowing for relaxation of previously compressed tissue and shifting of the brain. Other confounding factors are cerebral edema and bleeding. Even so, these systems still pay dividends by allowing the surgeon to plan the procedure in virtual space and to have some idea of the anatomy that will be encountered.
Other technologies, such as intraoperative MR imaging and ultrasonography, also play a role in neurosurgical operating rooms. Intraoperative MR imaging has the advantage of allowing repeated acquisition of images in the patient while the craniotomy is open, enabling resection of any remaining tumor. The MR imaging modality can be used to update the information in the neuronavigational systems, 4, 10, 32, 33 thereby minimizing the confounding factor of brain shift. 29, 31 As higher-powered MR imaging units are adapted to the operating room, it will also be possible to use such features as functional, diffusion-weighted, and spectroscopic images, and to integrate these with neuronavigator systems.
Another technology that is proving useful in brain tumor resection is ultrasonography. Due to the difference in impedance between normal brain and tumor, it is possible to identify remnants of tumor after a resection. Ultrasonography has the advantages of lower cost, decreased operating time, and ease of use compared with intraoperative MR imaging. With newer neuronavigational systems it is possible to merge ultrasonographic data with MR imaging or computerized tomography scans, thereby augmenting the surgeon's view of the tumor. Studies have shown that ultrasonography-based systems can provide accuracy comparable to that of traditional MR imaging-based systems. 26 Although these advances in technology have been amazing steps in the advancement of the field, their utility in all tumor resections has yet to be adequately defined. The role of surgery in the treatment of malignant glioma is somewhat controversial. Malignant glioma has perhaps the worst prognosis of any tumor, with the median survival duration well below 18 months, despite all advances in technology and treatment. 28 There is an accruing body of evidence (although this evidence is "not of high quality") 18 showing a survival advantage for extensive resection at the time of diagnosis in patients with low-grade gliomas. 19 The correlation of the extent of resection with survival in patients with high-grade gliomas is even less well defined. A number of studies detail a favorable effect of early, extensive resection in patients with malignant astrocytomas, 1, 2, 7, 8, 16, 17, 20, 22, 24, 25, 36, 37 whereas other studies have failed to show this benefit. 5, 6, [13] [14] [15] 23, 30, 34, 40 Still others have indicated that age and preoperative KPS score are better predictors of a favorable outcome than extent of resection. 21, 35 These results are complicated by that fact that the extent of resection is usually based on the surgeon's description rather than on postoperative imaging. 17 Several in-depth reviews of the literature have cited a number of flaws in design and analysis in papers dealing with the extent of glioma resection. 21, 30, 34 Data regarding the potential of neuronavigation to improve the outcomes of glioma treatment are minimal. One retrospective study of 76 patients in which neuronavigation and extent of resection were considered indicated a survival advantage of both GTR (16 months compared with 9 months) and the use of neuronavigation (16 months compared with 10 months). 24 Given the potential survival advantage of more extensive resection in patients with high-grade gliomas, we hypothesize that the use of intraoperative imaging technology or neuronavigation systems allows for more complete resections and, in turn, increased survival and improved outcome in these patients.
Clinical Material and Methods

The Registry
The GO Project is a multicenter, longitudinal, observational registry designed to track patterns of clinical practice and outcomes in patients who undergo surgery for malignant glioma. 3 One hundred fifty-seven self-selected physicians at 57 clinical sites volunteered to enroll patients in the GO Project through a process approved by an institutional review board. 27 The patient's informed consent was required for participation in the study.
Both physicians and patients completed standardized data sheets in the immediate postoperative period and then at 3-month intervals, for a total 24-month follow-up period. Data included demographic information, preoperative symptoms, functional status, treatment, medication status, postoperative complications, and patient satisfaction. Tumor-specific data included lesion size, location, histological grade, and pathological findings. Data regarding the surgical procedure, including type of procedure performed and the use of image guidance, were also recorded. Quality of life was measured using validated questionnaires, including the Short Form-36 Health Status Survey 39 and the GO Questionnaire. 3 Physicians at each site were educated by a coordinator to obtain standardized responses to the questions.
Enrollment criteria included adult patients undergoing biopsy sampling or a first or second resection for one of the following primary brain tumors: GBM, anaplastic astrocytoma, anaplastic oligodendroglioma, mixed anaplastic oligo/astrocytoma, or other anaplastic glioma. All patients were at least 18 years of age and were judged capable of giving informed consent. The GO Project began collecting patient data in 1997 and stopped enrolling patients in 2001. Our analysis included patients enrolled between December 1997 and July 2000.
The primary outcome measures included the following: 1) survival; 2) complications, including depression, seizures, and deep venous thrombosis; 3) quality of life over time; 4) patient satisfaction; 5) participation in clinical trials; 6) use of alternative therapies; and 7) duration of hospital stay. 27 
Patient Selection
Data obtained in 486 patients were analyzed in this study. Two groups of patients were compared: those with and those without IGR. For inclusion in this study, patients must have undergone a craniotomy for tumor resection or biopsy sampling. Patients who had undergone a stereotactic biopsy procedure performed in a bur-hole or twist-drill fashion were excluded. The type of image guidance used was not specified in the GO data. Outcome parameters included disposition of the patient at discharge; duration of hospital stay; neurological status; KPS score at 6, 9, and 12 months postoperatively; and death at 6, 9, and 12 months postoperatively.
Statistical Methods
Categorical variables are expressed as frequencies and percentages, and continuous variables are expressed as a median. For univariate analysis, categorical variables were analyzed using the chi-square test or the Fisher exact test, and continuous variables were analyzed using a t-test in addition to the Wilcoxon rank-sum test. For multivariate analysis, variables were screened for entry into the logistic regression model by using the chi-square test. For the multiple linear regression model predicting duration of hospital stay, a log transformation of the dependent variable was used due to the distribution. The model was then assessed for goodness of fit by using regression statistical diagnostic methods, including the Cook-Weisberg test for heteroscedasticity. The statistical analysis was performed using commercially available statistical software (SAS version 8.2; SAS Institute, Cary, NC). Table 1 summarizes the clinical characteristics of all 486 patients, 305 of whom had standard resections without image guidance, whereas 172 had image-guided craniotomies. Parts of the data were missing for nine patients, which accounts for the variability in the numbers of patients included in the analysis. Patients who underwent IGR were significantly younger than those who did not (50 years compared with 56 years; p Ͻ 0.01). They were also less likely to have certain clinical symptoms such as altered level of consciousness (12.2% compared with 21.3%; p Ͻ 0.02) or memory loss (30.2% compared with 40.0%; p Ͻ 0.04). Patients who underwent IGR were more likely to present with seizures than those who underwent standard resections (39.5% compared with 27.2%; p Ͻ 0.01). They were also more likely to have a tumor less than or equal to 4 cm in diameter (51.7% compared with 36.4%; p Ͻ 0.003), and less likely to have a pathological finding of GBM (65.7% compared with 79.7%; p Ͻ 0.002).
Results
The outcomes data are presented in Table 2 . The median duration of hospital stay in patients who underwent IGR was 3 days, whereas in patients who did not undergo IGR it was 4 days (p Ͻ 0.0001). Also, more patients who underwent IGR were discharged home with the ability to live independently than were those who were not treated with this procedure (p = 0.0003, data unavailable for 18% of patients), and the death rate at 6, 9, and 12 months was significantly lower (p Ͻ 0.05). In a subsequent multivariate analysis of the mortality rate, a diagnosis of pathological conditions other than GBM and younger age accounted for the decreases in this rate (p Ͻ 0.0001). Multivariate analysis did confirm the roles of IGR (p Ͻ 0.008) and younger age (p Ͻ 0.003) as significant predictors of independent status on discharge home and decreased duration of hospital stay. Interestingly, a significantly higher percentage of patients who underwent IGR had subtotal resection than those in whom no image guidance was used (44% compared with 35.1%; p Ͻ 0.0001, Fig 1) .
Discussion
These data show a surprising lack of IGR in patients with malignant glioma. Image guidance was used during the resection in only 172 (35%) of 486 patients in this study. Our findings in this study cannot answer precisely why image-guided surgery is not routine. However, we did not take into account the depth of tumor from the cortical surface, which may provide one explanation. Surgeons may be less likely to take the time to set up and use image-guidance technology for tumors that are superficial and easily identifiable at the cortex. Alternatively, because the role of extent of resection in GBMs is controversial, some surgeons may believe that IGR provides little benefit to this group of patients. Large tumors can be more easily located without image guidance, and the brain shift that occurs can cause radiographically depicted tumor margins to vary (sometimes significantly) from real margins. Surgeons may think that the time required for setting up is not worth any potential benefits that might be realized.
Preoperative clinical characteristics differed between patients who underwent IGR and those who did not. These differences are probably important factors in the decision to use image-guided surgical techniques. The IGR procedure was more likely to be used in younger patients presenting with seizures and a normal level of consciousness who had smaller, less aggressive tumors. In several studies these characteristics have been identified as conferring a better prognosis. 9, 28, 30 This selection bias supports the suggestion that IGR is used to maximize treatment in patients with a more favorable prognosis. Analysis of postoperative outcomes is consistent with this pattern, in that patients who underwent IGR had a shorter duration of hospital stay, were more likely to be discharged home with the ability to live independently, and were less likely to die. It is not possible to separate the effects of IGR from the selection bias toward patients with a better prognosis, given the design of this
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Patient selection factors and outcome for IGR of high-grade glioma 3 study. It is possible that the survival benefits of IGR have not yet been realized in the subgroup of patients with poorer prognoses. Image guidance, when applied to older patients with larger tumors and more severe symptoms at diagnosis, may help to improve this poor prognosis. Further study in this area is warranted. Currently, surgeons may be contributing to a self-fulfilling prophecy; patients with favorable characteristics are treated more aggressively and do better, whereas those with less favorable characteristics are treated less aggressively and thus are more likely to have a poor outcome. Strangely, in this study, patients who underwent IGR were less likely to attain a GTR. Considering the premise that image guidance would allow better definition of the borders of the tumor and subsequently a more precise resection, we find this result paradoxical. It is impossible to determine the factors involved in this observation based on our data. We believe that brain shift during frameless stereotaxy may cause an intraoperative impression that GTR was achieved, and that only with postoperative imaging is it revealed that the resection was subtotal.
Along with brain shift, the number and placement of fiducial markers can critically alter the accuracy of neuronavigational systems. With a small number of clustered fiducials, error can range as high as 9.5 mm. 38 Newer trends toward intraoperative MR imaging and ultrasonography combined with frameless navigational systems may help resolve this issue. This finding also leads us to suggest that surgeons who do use image-guided techniques may rely too heavily on the imaging in determining the extent of the resection, perhaps ignoring cues provided by the appearance and texture of the tissue. It is important for surgeons to remember that even the best navigational systems and imaging cannot replace the keen eye and clinical judgment of a well-trained neurosurgeon.
Unfortunately the retrospective questionnaire design of this study does not allow evaluation of exactly which IGR techniques were used. Presumably, real-time techniques such as intraoperative MR imaging and ultrasonography would be more likely to approach GTR than frameless stereotaxy. It is also likely that newer advances in functional MR imaging and labeling techniques will allow for less postoperative morbidity from damage to eloquent structures. Finally, the inherent weakness of the GO Project must be kept in mind: many diverse physicians enrolled only a few patients per doctor. As a result, considerable differences may exist between the IGR and non-IGR groups.
Conclusions
Patient characteristics associated with the use of IGR include younger age, seizures, and normal level of consciousness at presentation, tumor size less than 4 cm in diameter, and non-GBM findings on histopathological studies. Outcomes such as duration of hospital stay, discharge disposition, and mortality rates appear to be improved in patients who undergo IGR. These latter outcomes may be the result of patient selection rather than the IGR techniques themselves. We may not know the true benefits of navigational technology until it is applied to a wider range of patients, namely those with a worse prognosis. The fact that patients who underwent IGR in this study were more likely to have a suboptimal resection is an important reminder for surgeons not to rely too heavily on technology, and to use neuronavigation to augment clinical judgment. Neuronavigational technology may be more valuable if brain shift can be eliminated. As imaging technology improves and neuronavigational equipment becomes more precise, we will likely see an increased presence of these techniques in neurosurgical operating suites, and they will be used for a wider range of procedures.
